Compare · MMM vs NYXH
MMM vs NYXH
Side-by-side comparison of 3M Company (MMM) and Nyxoah SA (NYXH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MMM and NYXH operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MMM is the larger of the two at $91.97B, about 1136.4x NYXH ($80.9M).
- MMM has been more active in the news (9 items in the past 4 weeks vs 5 for NYXH).
- MMM has more recent analyst coverage (25 ratings vs 9 for NYXH).
- Company
- 3M Company
- Nyxoah SA
- Price
- -
- -
- Market cap
- $91.97B
- $80.9M
- 1M return
- +1.39%
- -
- 1Y return
- +5.91%
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 9
- 5
- Recent ratings
- 25
- 9
3M Company
3M Company develops, manufactures, and markets various products worldwide. It operates through four business segments: Safety and Industrial, Transportation and Electronics, Health Care, and Consumer. The Safety and Industrial segment offers personal safety products, industrial adhesives and tapes, abrasives, closure and masking systems, electrical markets, automotive aftermarket, and roofing granules to industrial, electrical, and safety markets. The Transportation and Electronics provides electronics, such as display materials and systems, electronic materials solutions; automotive and aerospace, and commercial solutions; advanced materials; and transportation safety products to transportation and electronic original equipment manufacturer customers. The Health Care segment offers medical and surgical supplies, skin health and infection prevention products, oral care, separation and purification sciences, health information systems, drug delivery systems, and food safety products to healthcare industry. The Consumer segment provides home improvement, home care, and consumer health care products, as well as stationery and office supplies to various consumers. This segment is also involved in the retail auto care business. It offers its products through various e-commerce and traditional wholesalers, retailers, jobbers, distributors, and dealers, as well as directly to users. 3M Company has a strategic collaboration with Merry Maids in residential cleaning sector; and collaborations with The Infectious Disease Research Institute and Duke Human Vaccine Institute to create a vaccine candidate with potential to provide protection against multiple variants of SARS-CoV-2. The company was founded in 1902 and is headquartered in St. Paul, Minnesota.
Nyxoah SA
Nyxoah S.A., a health-technology company, focuses on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. It offers Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treast moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is based in Mont-Saint-Guibert, Belgium.
Latest MMM
- 3M Announces Upcoming Investor Event
- New 3M™ Cooling Film helps fleet and rail operators keep cabin interiors cooler and improve efficiency
- 3M downgraded by Wolfe Research
- The Dow Rallies Back Above a Key Average, but Five Charts Made Even Bigger Moves Today
- 3M Reaches Broad Resolution of AFFF Personal Injury Litigation
- 3M Board Approves New $6 Billion Share Repurchase Authorization, Declares Quarterly Dividend
- Meguiar’s® Reveals Ford F-100 & Aston Martin GT3 in its 2026 SEMA Booth
- EVP Chief Strategy Officer Van Wyck Jonathan G. exercised 1,501 shares at a strike of $174.34 and covered exercise/tax liability with 460 shares, increasing direct ownership by 400% to 1,302 units (SEC Form 4)
- Meguiar’s® Unleashes a Trove of New 2027 Car Care Products: Continuing 125 Years of Innovation!
- 3M and AWS collaborate to advance optical connectivity innovation
Latest NYXH
- SEC Form 6-K filed by Nyxoah SA
- Nyxoah Obtains Default Decision Against Inspire Medical Systems in Unified Patent Court Case
- SEC Form 6-K filed by Nyxoah SA
- Nyxoah Reports Third Quarter 2026 Financial and Operating Results
- Nyxoah to Release Third Quarter 2026 Financial Results on November 5, 2026
- SEC Form 6-K filed by Nyxoah SA
- Nyxoah Announces Preliminary Results for the Third Quarter of 2026 and Adjusts Revenue Guidance for 2026
- Full 12-Month Data from the ACCCESS U.S. Pivotal Study in Complete Concentric Collapse Patients Presented at ISSS 2026
- SEC Form 6-K filed by Nyxoah SA
- Nyxoah Appoints Liam Kelly as Chief Executive Officer